This analysis details a comprehensive equipment procurement inquiry from an international investment group establishing a greenfield pharmaceutical manufacturing plant in Uzbekistan. The facility’s initial production mandate focuses on solid dosage forms (tablets) and herbal oral liquids. To support this infrastructure, the project requires a fully integrated suite of processing, primary packaging, and secondary packaging equipment.
2. Upstream Solid Dosage Processing
For the primary manufacturing of tablet formulations, the project scope specifies two core pieces of processing architecture:
GZP-26 Rotary Tablet Press: Engineered for medium-to-high capacity tablet compression. This system will serve as the foundational mechanical platform for converting granular formulations into precise solid dosages, with capabilities for handling complex multi-layer configurations if required.
BG-40E Film Coating Machine: Following compression, the tablets will be processed through this automated coating system. It is designed to apply precise film coatings to enhance tablet stability, control dissolution rates, and improve swallowability, utilizing advanced thermal and spray atomization controls.
3. Blister Packaging Architecture Evaluation
For primary packaging, the facility is concurrently evaluating two distinct mechanical blister packaging platforms to determine the optimal balance between format versatility and volumetric throughput:
DPP-260Ki-2 (Platen Sealing): An intermittent-motion architecture ideal for complex solid dosage geometries and deep-draw thermoforming or cold-forming requirements. It offers high flexibility for frequent format changeovers.
DPH-260 (Rotary Sealing): A continuous-motion, high-speed architecture designed for steady-state, high-yield commercial production runs, maximizing Overall Equipment Effectiveness (OEE) for standard blister formats.